This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
And today, we’re proud to say that AlphaSense is the world’s most robust marketintelligence search platform for professionals across all industries. As we look to the future, we’re excited about how we’ll keep our customers ahead of the market through innovations in generative AI (genAI). Our solution?
That’s why more and more pharma companies are leveraging marketintelligence platforms to see what their competition , Wall Street, and the industry is saying and to find the answers they need. And to aid providers , pharmaceutical manufacturers are incorporating AI to assist medical professionals in their patient consultations (i.e.,
Data visualizations on the platform not only help you uncover actionable consumer and marketintelligence , but they also aid in sharing your intel to anyone within your organization, so they comprehend the scope of the story the data tells at a glance. Reputology.
While the United States manufacturing sector took a hit from COVID-19-spawned disruptions, it is important to note that the industry churns out the goods needed to sustain the needs and wants of the world’s largest consumer market. She spent two years at KLA as marketintelligence manager. As of 2019, there were some 12.8
Industry and Market Analysis – Analyzing broader industry trends and market dynamics that can affect healthcare companies’ performance by assessing factors such as regulatory changes, technological advancements, demographic shifts, and healthcare policies.
Below, we explore the factors constraining venture capital funding into the first half of the year, and the ways investors can leverage crucial marketintelligence to gain a competitive advantage in the shifting landscape. The VC Funding Dryspell Venture capital investment fell to the lowest activity in nearly five years for Q1 2024.
Regardless of this divergence in opinion, weight loss drugs like Ozempic, Wegovy, and Mounjaro offer a promising opportunity in the healthcare and pharmaceuticalmarket, with innovation and research continually striving to provide safer and more effective solutions for those in need. And the market is just huge.”
Singapore is home to some of the largest regional companies and multinationals in Asia and is a global hub for tech and innovation—making it a natural fit as a regional hub for AlphaSense that will complement our existing innovation and engineering hubs in India, and offices around the world. Read the full press release here.
Precision medicine is an innovative approach to prevent and treat diseases by taking into account the individual distinction between genetic make-up, lifestyle, and environment of an individual. It is sometimes also known as personalized medicine. billion in 2018 and is expected to reach $216.75 billion by 2028.
Expert networks are a critical tool for marketintelligence and are leveraged by professionals to gain firsthand knowledge of specialized industries, companies, and markets. Calculate the return on investment (ROI) of your marketintelligence by using our ROI calculator.
The right to challenge assumptions (A) An internal market analyst should be expected to challenge internal assumptions that are not robust. The analyst should be drawing on a variety of both primary and secondary intelligence. How often are we surprised by a non-direct competitor launching a radical innovation?
timber, natural pharmaceuticals) and services (i.e., Using our innovativemarketintelligence platform, our clients can access broker research, company documents, and more from over 10,000 plus content sources–ensuring that our users have all the information they need. AlphaSense is that and more.
Owing to the applications of microbiology testing across various industries, such as pharmaceutical, food and beverage, dairy, agriculture and fermentation, paper, biotechnology, and water & environmental industry, the global industrial microbiology market is projected to witness significant growth during the forecast period, 2019-2028.
2 Next, we grouped pharmaceutical sponsors/collaborators by their Scrip 100 industry rankings into two groups: top 20 pharma and all other pharma. Our Approach to this Analysis: We started by analyzing pharma-sponsored clinical trials, 1 initiated between 2018 and 2022, for only unapproved primary immuno-oncology (IO) drugs.
He is known for his empathetic manner as well as his team building, accountability, mentorship, and innovation. Pharmaceutical and medical device companies may consult with a KOL when it comes to development and testing. And that’s because they can provide unique insights, such as product improvement or even market messaging.
Under these programs, “prescription drug spending accounts for a significant portion of national pharmaceutical spending, which totaled $577 billion in 2021, and supply-chain complexity has complicated efforts to track the flow of these dollars.” So maybe the PBMs are to blame.
AlphaSense, a leading AI-based marketintelligence platform , provides Expert Insights alongside an extensive universe of private, public, and premium content. A fully realized M&A research strategy incorporates the power of Expert Insights and an all-in-one marketintelligence platform to maximize return on investment (ROI).
User-Friendly UI & Collaboration Known for its intuitive, user-friendly interface, AlphaSense’s marketintelligence platform was designed and built to be easily integrated into an organization’s existing systems processes.
From identifying potential drug candidates and optimizing molecular structures to streamlining clinical trial design and enhancing personalized medicine , this technology is driving unprecedented efficiency and innovation. According to Precedence Research , the AI market within the healthcare sector is projected to surpass $20.6
This emerging trend is allowing pharmaceutical companies—large and small—to distinguish themselves among competitors and investors as they pioneer advancements fueled by AI. The ability to bring drugs and therapies to market sooner, with less intrinsic cost, ultimately leads to stronger valuations and greater stakeholder value.
Instead, they are turning to a more centralized approach to research and are using artificial intelligence (AI) to help them filter through the noise, inform more confident decision-making, and share marketintelligence with their broader organizations. See for yourself how AlphaSense can transform your research.
Trade journals Provide insight into key industry trends and evolving market dynamics, while also highlighting thought leadership and regulatory updates for better understanding of specific industries and key players. This data is highly useful for identifying potential competitive threats and opportunities.
Trade journals Provide insight into key industry trends and evolving market dynamics, while also highlighting thought leadership and regulatory updates for better understanding of specific industries and key players. This data is highly useful for identifying potential competitive threats and opportunities.
Data show American companies are now outpacing their European counterparts in growth and innovation, and the European Central Bank attributes the US outpacing Europe to labor market churn and higher investment in digitalization. It seems to lead to continental divide. Nicolai Tangen, head of the Norwegian $1.6
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content